Sort
326,823 grants matching “clinical trial”
BACE1 in neurodegeneration and neurological dysfunction
$2,139,908Riqiang Yan · University Of Connecticut Sch Of Med/Dnt · RF1 · FY2021 · NS
A Pilot Clinical Trial for HIV-1 Eradication
$2,139,888Mathias Lichterfeld · Brigham And Women'S Hospital · U01 · FY2016 · AI
Neuroblastoma Biology and Therapy
$2,139,824Childrens Hospital Of Philadelphia · P01 · FY2005 · CA
MEHARRY CLINICAL RESEARCH CENTER
$2,139,793Valerie C. Montgomery-Rice · Meharry Medical College · P20 · FY2007 · RR
AAV Gene Therapy for Lipid Disorders
$2,139,766James M Wilson · University Of Pennsylvania · P01 · FY2018 · HL
CLINICAL TRIAL REGEN MED PAIN SENSORY SYS
$2,139,753Brigham & Womens Hospital Inc · · FY2012 · Department of Defense
The Genetics Of Biobehavioral Risk Factors For CVD
$2,139,715Duke University · P01 · FY2004 · HL
MEHARRY CLINICAL RESEARCH CENTER
$2,139,517Valerie C. Montgomery-Rice · Meharry Medical College · P20 · FY2006 · RR
Developmental and Hyperactive Ras Tumor (DHART) SPORE
$2,139,494David W. Clapp · Indiana University Indianapolis · U54 · FY2022 · CA
Developmental and Hyperactive Ras Tumor (DHART) SPORE
$2,139,494David W. Clapp · Indiana University Indianapolis · U54 · FY2023 · CA
Canine Hereditary Cancer Consortium: From Bark to Bedside
$2,139,485Jeffrey M. Trent · Translational Genomics Research Inst · UC2 · FY2010 · CA
Lymphoma Specialized Program of Research Excellence (SPORE)
$2,139,354George J Weiner · University Of Iowa · P50 · FY2011 · CA
Noroviruses and Epidemic Gastroenteritis
$2,139,101Kim Y. Green · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
PLCO Trial Etiologic and Early Marker Study
$2,139,074Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
UCLA SPORE in Brain Cancer
$2,139,000Linda M Liau · University Of California Los Angeles · P50 · FY2019 · CA
SPORE for Translational Approaches to Brain Cancer
$2,139,000Maciej S Lesniak · Northwestern University At Chicago · P50 · FY2019 · CA
UCLA SPORE in Brain Cancer
$2,139,000Linda M Liau · University Of California Los Angeles · P50 · FY2021 · CA
Mayo Clinic Ovarian Cancer SPORE
$2,139,000Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2019 · CA
SPORE for Translational Approaches to Brain Cancer
$2,139,000Maciej S Lesniak · Northwestern University At Chicago · P50 · FY2021 · CA
SPORE in Myeloid Malignancies
$2,138,999Benjamin Levine Ebert · Dana-Farber Cancer Inst · P50 · FY2019 · CA
Administrative Core A
$2,138,999Benjamin Levine Ebert · Dana-Farber Cancer Inst · P50 · FY2019 · CA
SPORE for Translational Approaches to Brain Cancer
$2,138,999Maciej S Lesniak · Northwestern University At Chicago · P50 · FY2022 · CA
SPORE in Myeloid Malignancies
$2,138,999Benjamin Levine Ebert · Dana-Farber Cancer Inst · P50 · FY2021 · CA
MSK SPORE in Lymphoma
$2,138,999Andrew D. Zelenetz · Sloan-Kettering Inst Can Research · P50 · FY2020 · CA
Topological Mapping of Immune, Microbiota, Metabolomic and Clinical Phenotypes to Reveal ME/CFS Disease Mechanisms
$2,138,950Derya Unutmaz · Jackson Laboratory · U54 · FY2021 · NS